Streetbeat News

Products Services

AAPL

The launch of Apple Inc.'s self-driving car, initially referred to as 'Project Titan', may not happen until later in the decade, according to Bloomberg's Mark Gurman. This comes after tech analyst Ming-Chi Kuo stated that he has 'lost all visibility' on the Apple Car project. Despite the long development period, the project has only consumed 4% of Apple's total R&D spend in 2022.

Portfolio Pulse from Ananya Gairola

November 06, 2023 | 7:32 am

TSLA

Vietnamese artist Truong Van Dao, known as NDWoodArt on Twitter, has created a functional wooden replica of Tesla's Cybertruck and expressed his desire to gift it to Tesla CEO Elon Musk. Musk responded positively to the offer. The artist has previously made wooden replicas of various vehicles. The first deliveries of the original Tesla-made Cybertruck are scheduled for November 30 at Gigafactory Texas.

Portfolio Pulse from Anan Ashraf

November 06, 2023 | 6:57 am

KHC

Heinz, a brand under Kraft Heinz Co (KHC), has announced the launch of Pickle Ketchup, a new condiment that combines the flavors of pickles and ketchup. This is the first Heinz innovation to launch globally after the brand's unification under one global creative platform. The product will be available in the United States in early 2024 and is currently rolling out in select retailers in the United Kingdom.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:53 am

TSLA

Tesla's self-driving software is under scrutiny after a video was posted on social media showing a Tesla vehicle failing to respond as expected in Autopilot mode. The video was reposted by Tesla short-seller Jim Chanos, who questioned why such issues are still occurring after eight years of development. GLJ Research's Gordon Johnson suggested that Tesla's lack of video collection, hi-resolution radar/Lidar, and care are probable reasons for the failure. He also criticized Wall Street analysts for valuing Tesla's 'future promise' of Full Self-Driving (FSD) at 'infinity'.

Portfolio Pulse from Shanthi Rexaline

November 06, 2023 | 6:45 am

VERA

Vera Therapeutics is set to present data from its Phase 2b ORIGIN study, which shows resolution of hematuria in the majority of patients. This could potentially boost the company's reputation in the medical field.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:42 am

APLS

Apellis Pharmaceuticals has presented data from the GALE extension study, which followed three years of continuous treatment with SYFOVRE (Pegcetacoplan Injection).

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:41 am

TLSI

Trisalus has presented additional Phase 1 clinical data during the Late-Breaker Oral Presentation Session at SITC 2023 Annual Meeting. The company's stock, TLSI, may be affected by this news.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:37 am

ADVM

Adverum Biotechnologies has announced 3-year efficacy and safety results from the OPTIC extension study in patients with Wet AMD at AAO 2023. The results are expected to have a significant impact on the company's future operations.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:28 am

OLK

Novogene Asia Pacific Middle East and Africa has adopted Olink® Explore HT technology to accelerate multi-omics research with next-generation proteomics. The technology is expected to enhance Novogene's research capabilities.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 6:27 am